Home > Healthcare > Medical Devices > Diagnostic Devices > point of care glucose testing market
Get a free sample of Point-of-Care Glucose Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Point-of-Care Glucose Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The point-of-care (POC) glucose testing industry is characterized by intense competition, with major global companies and smaller to medium-sized firms vying for market leadership. Key strategies for maintaining a competitive edge include the regular introduction of innovative technologies and products. Leading industry players drive innovation through significant investments in research and development.
Furthermore, strategic partnerships, acquisitions, and mergers are crucial for consolidating market positions and expanding international reach, enabling companies to enhance their market presence and leverage new opportunities. Smaller players are focusing on specific niches or bringing innovative approaches to POC testing. These companies often target underserved areas or specific medical conditions, creating competitive pressure on established players.
Some of the eminent market participants operating in the point-of-care glucose testing industry include:
The point-of-care glucose testing market was valued at USD 3.4 billion in 2023 and will witness a 4.7% CAGR between 2024 and 2032 driven by the rising incidence of diabetes.
The test strips segment in the point-of-care glucose testing industry will attain USD 2.3 billion by 2032, due to their high accuracy and precision in glucose measurement.
U.S. point-of-care glucose testing market is expected to surpass USD 1.9 billion by 2032, owing to the highest diabetes prevalence rates, along with a well-established healthcare infrastructure that supports the widespread use of advanced medical technologies.
Abbott Laboratories, ARKRAY, Inc., ACON Laboratories, Inc., B. Braun Melsungen AG, and Dexcom, Inc., among others.